Patients With Neuroendocrine Tumors May Value QOL Over Survival
Many patients with advanced neuroendocrine tumors may value preserving their quality of life over extending their survival.
Stay updated with breaking news from Later Tool. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Many patients with advanced neuroendocrine tumors may value preserving their quality of life over extending their survival.
Independence is valued over survival among adult patients with neuroendocrine tumors (NETs).
Many patients with advanced neuroendocrine tumors may value preserving their quality of life over extending their survival.
FRIDAY, Dec. 30, 2022 (HealthDay News) -- Independence is valued over survival among adult patients with neuroendocrine tumors (NETs), according to a study published in the December issue of the Journal of the National Comprehensive Cancer Network. Daneng Li, M.D., from City of Hope in Duarte, California, and colleagues examined patient values toward treatment goals
Many patients with advanced neuroendocrine tumors may value preserving their quality of life over extending their survival.